Table 3.

Subgroup analysis of NIBS on PSCI patients.

Subgroup analysis		Studies	SMD (95% CI)	P	X 2	I2 (%)	Tau2
MoCA
Intervention length	< 4w	4	0.44 [0.10, 0.79]	0.01	4.05	1%	0.00
	≥4w	9	0.89 [0.57, 1.22]	< 0.0001	21.59	63%	0.15
MMSE
Intervention length	< 4w	3	0.29 [−0.08, 0.67]	0.28	3.80	21%	0.03
	≥4w	5	1.04 [0.34, 1.74]	0.003	24.97	84%	0.53
MBI, FIM
Intervention length	< 4w	4	0.01 [−0.30, 0.32]	0.95	2.59	0%	0.00
	≥4w	4	0.69 [0.12, 1.27]	0.02	0.51	72%	0.24